The Perceived Effects of Smoked Cannabis on Patients with Multiple SclerosisConsroe P. · Musty R. · Rein J. · Tillery W. · Pertwee R.
Departments of a Pharmacology/Toxicology and b Academic Resources, University of Arizona Health Sciences Center, Tucson, Ariz., c Department of Psychology, University of Vermont, Burlington, Vt., USA; d Institute of Medical Sciences, University of Aberdeen, Scotland, UK
Fifty-three UK and 59 USA people with multiple sclerosis (MS) answered anonymously the first questionnaire on cannabis use and MS. From 97 to 30% of the subjects reported cannabis improved (in descending rank order): spasticity, chronic pain of extremities, acute paroxysmal phenomenon, tremor, emotional dysfunction, anorexia/weight loss, fatigue states, double vision, sexual dysfunction, bowel and bladder dysfunctions, vision dimness, dysfunctions of walking and balance, and memory loss. The MS subjects surveyed have specific therapeutic reasons for smoking cannabis. The survey findings will aid in the design of a clinical trial of cannabis or cannabinoid administration to MS patients or to other patients with similar signs or symptoms.
Professor Paul Consroe, Department of Pharmacology/Toxicology, College of Pharmacy, University of Arizona, PO Box 210207, Tucson, AZ 85721-0207 (USA), Tel. (520) 6262884, Fax (520) 6262466, E-Mail email@example.com
Received: August 19, 1996
Accepted: February 14, 1997
Published online: December 20, 2007
Number of Print Pages : 5
Vol. 38, No. 1, Year 1997 (Cover Date: 1997)
Journal Editor: Bogousslavsky, J. (Montreux)
ISSN: 0014–3022 (print), 1421–9913 (Online)
For additional information: http://www.karger.com/ENE
|Direct payment||This item at the regular price: USD 38.00|
|Payment from account||With a Karger Pay-per-View account (down payment USD 150)
you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50